Infection with Human Immunodeficiency Virus (HIV) results in several important pathologic manifestations. The most apparent and perhaps the best studied are its devastating effects on the immune and the central nervous systems (CNS). Although progress has been made on determining the mechanisms of lymphopenia, the proximate cause of immune deficiency, dysregulation of other bone marrow derived lineages is poorly understood. The development of a simian model of AIDS permits us to study pathogenesis in the laboratory environment. Important variables such as virus strain, dose, route and time of infections will be experimentally controlled. The expertise provided by the other participating investigators will allow us to correlate our findings with neuropathologic data, a third important pathologic manifestation. The primary objectives of this project, therefore, are: 1) to characterize the changes in bone marrow organization and function that occur following Simian Immunodeficiency Virus (SIV) infection of Rhesus monkeys, 2) to assess immunopathogenesis in infected animals, 3) to determine the effects of viral infection on progenitor growth, differentiation, and growth factor production and, 4) identify progenitor populations susceptible to viral infection using neurotropic and non-neurotropic strains. These studies will be conducted using tissues from experimentally infected animals as well as in vitro infected material from healthy animals. From the proposed studies we hope to gain a better understanding of the mechanisms of SIV/HIV induced dysregulation of bone marrow function and correlate these changes with CNS disease and immune deficiency.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Su, Y; Popik, W; Pitha, P M (1995) Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells. J Virol 69:110-21
Joag, S V; Stephens, E B; Adams, R J et al. (1994) Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 200:436-46
Zhong, R K; Donnenberg, A D; Rubin, J et al. (1994) Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Blood 83:2345-51
Joag, S V; Adams, R J; Pinson, D M et al. (1994) Intracerebral infusion of TNF-alpha and IL-6 failed to activate latent SIV infection in the brains of macaques inoculated with macrophage-tropic neuroadapted SIVmac. J Leukoc Biol 56:353-7
Clements, J E; Anderson, M G; Zink, M C et al. (1994) The SIV model of AIDS encephalopathy. Role of neurotropic viruses in diseases. Res Publ Assoc Res Nerv Ment Dis 72:147-57
Shirazi, Y; Popik, W; Pitha, P M (1994) Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. J Interferon Res 14:259-63
Shirazi, Y; Pitha, P M (1993) Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 193:303-12
Popik, W; Pitha, P M (1993) Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1. J Virol 67:1094-9
Joag, S V; Narayan, O (1993) Immunodeficiency-inducing retroviruses. Curr Opin Immunol 5:595-9
Anderson, M G; Hauer, D; Sharma, D P et al. (1993) Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology 195:616-26

Showing the most recent 10 out of 30 publications